Q2 2020 Holdings
Filed 2020-08-12 | 15 holdings | $143.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals(ARWR) | COM | 04280A100 | $140.8M | 3,260,869 | 98.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $2.5M | 594,834 | 1.7% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $115.9K | 3,379,064 | 0.1% |
| Legend Biotech Corporation(LEGN) | SPONSORED ADS | 52490G102 | $69.3K | 1,629,173 | 0.0% |
| Fusion Pharmaceuticals Inc. | COM | 36118A100 | $64.1K | 3,670,516 | 0.0% |
| Protagonist Therapeutics Inc.(PTGX) | COM | 74366E102 | $43.3K | 2,449,183 | 0.0% |
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $36.3K | 2,898,550 | 0.0% |
| Provention Bio, Inc.(PRVBUSD) | COM | 74374N102 | $15.9K | 1,124,973 | 0.0% |
| BiomX Inc. | COM | 09090D103 | $11.8K | 2,133,402 | 0.0% |
| PhaseBio Pharmaceuticals, Inc. | COM | 717224109 | $7.4K | 1,607,044 | 0.0% |
| Castlight Health Inc.(CSLT1EUR) | CL B | 14862Q100 | $673 | 811,295 | 0.0% |
| Catalyst Biosciences, Inc. | COM | 14888D208 | $393 | 66,951 | 0.0% |
| Genocea Biosciences, Inc.(GNCAQ) | COM | 372427401 | $331 | 143,964 | 0.0% |
| Senseonics Holdings, Inc.(SENS1GBP) | COM | 81727U105 | $205 | 525,632 | 0.0% |
| Tracon Pharmaceuticals, Inc. | COM | 89237H209 | $165 | 84,003 | 0.0% |